| Time between symptom onset, hospitalisation and recovery or death: statistical analysis of Belgian COVID-19 patients C Faes, S Abrams, D Van Beckhoven, G Meyfroidt, E Vlieghe, N Hens, ... International journal of environmental research and public health 17 (20), 7560, 2020 | 288* | 2020 |
| Seroprevalence of IgG antibodies against SARS-CoV-2–a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020 SA Herzog, J De Bie, S Abrams, I Wouters, E Ekinci, L Patteet, A Coppens, ... Eurosurveillance 27 (9), 2100419, 2022 | 105 | 2022 |
| Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories S Abrams, J Wambua, E Santermans, L Willem, E Kuylen, P Coletti, ... Epidemics 35, 100449, 2021 | 102 | 2021 |
| COVID-19 mortality, excess mortality, deaths per million and infection fatality ratio, Belgium, 9 March 2020 to 28 June 2020 G Molenberghs, C Faes, J Verbeeck, P Deboosere, S Abrams, L Willem, ... Eurosurveillance 27 (7), 2002060, 2022 | 89* | 2022 |
| The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19 L Willem, S Abrams, PJK Libin, P Coletti, E Kuylen, O Petrof, ... Nature communications 12 (1), 1524, 2021 | 85 | 2021 |
| Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis J Schenk, S Abrams, H Theeten, P Van Damme, P Beutels, N Hens The Lancet Infectious Diseases 21 (2), 286-295, 2021 | 62 | 2021 |
| A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies P Coletti, P Libin, O Petrof, L Willem, S Abrams, SA Herzog, C Faes, ... BMC infectious diseases 21, 1-12, 2021 | 55 | 2021 |
| Resurgence risk for measles, mumps and rubella in France in 2018 and 2020 G Béraud, S Abrams, P Beutels, B Dervaux, N Hens Eurosurveillance 23 (25), 1700796, 2018 | 55 | 2018 |
| Donor‐derived cell‐free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta‐analysis VPWM Wijtvliet, P Plaeke, S Abrams, N Hens, EM Gielis, R Hellemans, ... Transplant International 33 (12), 1626-1642, 2020 | 53 | 2020 |
| Level of cardiovascular disease knowledge, risk perception and intention towards healthy lifestyle and socioeconomic disparities among adults in vulnerable communities of … HY Hassen, M Bowyer, L Gibson, S Abrams, H Bastiaens BMC Public Health 22 (1), 197, 2022 | 42 | 2022 |
| Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013 N Hens, S Abrams, E Santermans, H Theeten, N Goeyvaerts, T Lernout, ... Eurosurveillance: European communicable disease bulletin/European …, 2015 | 36 | 2015 |
| Community-based interventions for cardiovascular disease prevention in low-and middle-income countries: a systematic review R Ndejjo, HY Hassen, RK Wanyenze, D Musoke, F Nuwaha, S Abrams, ... Public health reviews 42, 1604018, 2021 | 29 | 2021 |
| Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data N Franco, P Coletti, L Willem, L Angeli, A Lajot, S Abrams, P Beutels, ... PLoS computational biology 18 (3), e1009965, 2022 | 27 | 2022 |
| Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country G Molenberghs, M Buyse, S Abrams, N Hens, P Beutels, C Faes, ... Contemporary Clinical Trials 99, 106189, 2020 | 27 | 2020 |
| Comparison of Diagnostic Tests for Onchocerca volvulus in the Democratic Republic of Congo A Hotterbeekx, J Perneel, M Mandro, G Abhafule, JN Siewe Fodjo, ... Pathogens 9 (6), 435, 2020 | 26 | 2020 |
| Effectiveness of community-based cardiovascular disease prevention interventions to improve physical activity: a systematic review and meta-regression HY Hassen, R Ndejjo, G Musinguzi, JP Van Geertruyden, S Abrams, ... Preventive medicine 153, 106797, 2021 | 25 | 2021 |
| Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data S Abrams, P Beutels, N Hens American journal of epidemiology 179 (8), 1006-1017, 2014 | 25 | 2014 |
| Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy treated with phenobarbital: a randomized clinical trial in the Democratic … M Mandro, JN Siewe Fodjo, A Dusabimana, D Mukendi, S Haesendonckx, ... Pathogens 9 (3), 205, 2020 | 23 | 2020 |
| Sample size calculation for estimating key epidemiological parameters using serological data and mathematical modelling S Blaizot, SA Herzog, S Abrams, H Theeten, A Litzroth, N Hens BMC Medical Research Methodology 19, 1-12, 2019 | 18 | 2019 |
| mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients? VPWM Wijtvliet, KK Ariën, S Abrams, MM Couttenye, F Mestrez, J Mariën, ... Nephrology Dialysis Transplantation 37 (4), 799-803, 2022 | 16 | 2022 |
Niel HensProfessor of BiostatisticsPotvrđena adresa e-pošte na uhasselt.be
